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Abstract 
 Transport of choline from the synaptic cleft into cholinergic neurons is mediated by the 
choline high-affinity transporter (CHT).  This process represents the rate-limiting step in the 
synthesis of acetylcholine (ACh), a neurotransmitter critically involved with processes requiring 
sustained attention.  Compromised CHT capacity limits the ability to release ACh and may be 
implicated in disorders affecting attention.  Mice hemizygous for the CHT gene were trained 
alongside wildtype (WT) littermates on a sustained attention task (SAT), and performance-
associated ACh release in the medial prefrontal cortex (mPFC) was determined through 
microdialysis.  CHT +/- mice express roughly half the amount of the CHT protein, and were 
predicted to show impaired performance on the SAT in addition to a reduced capacity to sustain 
elevated levels of ACh release.  We found no differences between WT and CHT +/- mice on 
measures of SAT performance, however task-associated ACh increases appeared to be greatly 
reduced in hemizygotes. In a complimentary experiment, we taxed cholinergic signaling 
pharmacologically by perfusing, via reverse dialysis, the muscarnic antagonist atropine, which 
causes increased ACh release in rats (Moore, Stuckman, Sarter, & Bruno, 1995).  We found CHT 
+/- mice are initially able to release levels of ACh equivalent to WT, but are unable to sustain 
elevated release for as long a period.  Together our data suggest that CHT +/- mice are limited in 
their capacity to sustain elevated ACh release, and further research is needed to explore both 
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compensatory mechanisms enabling good performance on attentionally demanding tasks, as well 
as limitations of CHT hemizygosity. 
ATTENTION AND ACETYLCHOLINE RELEASE IN CHT +/- MICE 
 
4
Sustained Attention and Associated Acetylcholine Release in  
Choline High-Affinity Transporter Hemizygous Mice 
 Cholinergic neurons originating in the basal forebrain and projecting widely throughout 
the cortex are critical in mediating attentional processes (Sarter, Givens, & Bruno, 2001). 
Sustained attention, the focus of our study, is characterized by the subjects’ ability to detect 
unpredictably occurring signals over a prolonged period.  The necessity of cortical cholinergic 
neurotransmission on maintaining sustained attentional performance has been demonstrated in 
rats through lesion studies, measurements of acetylcholine (ACh) during task performance, and 
pharmacological manipulations  (Sarter & Parikh, 2005).  In particular, ACh signaling within the 
right medial prefrontal cortex (mPFC) appears to be critical for performance on the sustained 
attention task (SAT).  Microdialysis studies have consistently found elevated levels of ACh in 
the right mPFC of rats performing the SAT and lesions to the right hemisphere cholinergic inputs 
impair signal detection (Martinez & Sarter, 2004).  Dysfunction of cholinergic neurotransmission 
compromises attentional abilities and is implicated in a number of cognitive impairments 
including aging and dementia (Sarter & Parikh, 2005).  It is therefore important to study the 
molecular mechanisms that contribute to compromised cholinergic signaling.   
 Of particular interest is the choline high-affinity transporter (CHT), which mediates high-
affinity uptake of choline into presynaptic neurons and limits the rate of ACh synthesis from 
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choline and Acetyl coenzyme A (Apparsundaram, Martinez, Parikh, Kozak, & Sarter, 2005).  In 
the brain, CHTs are found within cholinergic neurons, both at the membrane and within vesicles 
in the membrane terminal.  CHT capacity for choline-uptake depends on the density of CHTs 
localized at the synaptosomal membrane, which is regulated by intracellular trafficking of CHTs 
from reserve stores to the terminal membrane (Sarter & Parikh, 2005).  While 15% of the reserve 
pool is constitutively trafficked to the synaptosomal membrane to maintain basal CHT capacity, 
increased trafficking is necessary to maintain sustained, elevated levels of ACh release, and is 
thought to be regulated by intracellular mechanisms independent of neuronal depolarization.  
Evidence in support of this model comes from findings that rats performing the SAT have a 
higher proportion of CHTs localized at the neuronal membrane in the right mPFC than rats 
performing a control task lacking explicit attentional demand (Apparsundaram et al., 2005).   
 Determining the mechanisms behind CHT regulation will help to understand diseases and 
abnormalities associated with alterations in CHT functioning.  It has been suggested that 
disruptions in CHT regulation may contribute to the declines in cholinergic transmission 
implicated in Alzheimer’s disease (Sarter & Parikh, 2005). Additionally, a short nucleotide 
polymorphism of the human CHT gene has been identified (Ile89Val) that is associated with a 
40-50% decrease in choline-uptake capacity (Okuda, Okamura, Kaitsuka, Haga, & Gurwitz, 
2002).  Present in 11% of the general population, this allele is overrepresented in the ADHD 
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population.  Compared to control subjects, humans heterozygous for the variant self-report 
higher distractibility and poorer concentration (unpublished findings, Sarter, 2009). 
 While CHT knockout mice die shortly after birth, CHT hemizygotes (CHT +/-) are fertile 
and viable, providing a model to study phenotypes associated with altered CHT functioning. 
Hemizygotes express 50% less CHT protein and display lower overall brain ACh levels, elevated 
choline levels, and decreased expression of muscarinic ACh receptors in certain brain regions 
(Bazalakova et al., 2007).  Under basal conditions, CHT +/- mice express equal amounts of CHT 
at the synaptosomal membrane, but have a disproportionately small intracellular reserve pool 
compared to WT (unpublished findings, Sarter, 2009).  This may explain why under basal 
conditions hemizygotes display normal ACh release and are largely indistinguishable from WT 
mice (Sarter & Parikh, 2005).  While CHT +/- mice perform equivalently to WT on measures of 
coordination, general activity, anxiety, and spatial learning and memory, they more quickly reach 
exhaustion on a treadmill test, and are less sensitive to the hyperlocomotive effects of the 
muscarinic ACh receptor antagonist scopolamine (Bazalakova et al., 2007).  It is hypothesized 
that processes that significantly tax cholinergic transmission may reveal impaired phenotypes in 
CHT +/- mice, due to their limited CHT capacity. 
In two experiments, we challenged cholinergic signaling behaviorally and 
pharmacologically to investigate differences in ACh release between WT and CHT +/- mice.   
ATTENTION AND ACETYLCHOLINE RELEASE IN CHT +/- MICE 
 
7
We first studied the impact of CHT hemizygosity on attentional performance and task-associated 
ACh release in the mPFC.  To assess differences in attentional capacity, WT and CHT +/- mice 
were trained on the SAT, which has been used extensively as a measure of sustained attention 
(McGaughly & Sarter, 1995).  SAT training begins with a discrimination task, in which animals 
must distinguish between the presence or absence of a signal.  In subsequent levels, the task 
becomes more attentionally challenging.  For example, the introduction of varying signal 
durations and the presence of a house light require the animal to maintain its focus towards the 
intelligence panel.   
As research with rats has consistently demonstrated increases in ACh release in the right 
mPFC during the SAT, a major goal of this study was to investigate the presence of a similar 
pattern in mice and determine if CHT +/- mice exhibit attenuated task-associated ACh release 
due to their reduced CHT capacity.  As predicted, WT ACh release looked similar to patterns 
observed in rats, while CHT +/- mice showed considerably less task-associated ACh release.  
Despite releasing less ACh during task, CHT +/- mice performed equivalently to WT on the 
SAT.   
To explore the possibility that the SAT does not sufficiently tax cholinergic transmission 
to reveal phenotype differences, we exposed mice to the distractor condition of the SAT (dSAT).  
In the dSAT, a visual distractor (house light flashes on/off at 0.5 Hz) is presented during a period 
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of the task.  This manipulation is associated with further increases in cholinergic activity in the 
mPFC, and is thought to demand increased attentional effort (Sarter, Gehring, & Kozak, 2006).  
Experiments in rats have found the greatest ACh release during presentation of the distractor (St. 
Peters, Demeter, Lustig, Bruno, & Sarter, 2011). We were interested to see how the distractor 
condition affects ACh release in CHT +/- mice, and how release patterns differ from WT.  
Preliminary data suggest that CHT +/- mice are more impaired on signal trials during the block 
following the distractor (unpublished findings, Sarter, 2009), suggesting that CHT trafficking is 
exhausted during distractor presentation.  According to this model, we expected to find increased 
ACh release during the distractor period, followed by low level release and poor performance in 
the post-distractor period.  Results from a preliminary dialysis session in a CHT +/- mouse 
performing the dSAT are discussed below.  Due to the limited time frame of this study, we were 
unable to obtain comprehensive dSAT data. 
As we found that CHT +/- mice are able to perform the SAT with surprisingly low levels 
of task-associated ACh release, we next explored whether this small increase was necessary for 
attentional performance.  We attempted to block ACh signaling in the mPFC by perfusing, via 
reverse dialysis, the muscarinic receptor antagonist atropine during a period of the task.  While 
atropine evokes ACh release, by inhibiting presynaptic autoreceptors located on cholinergic 
neurons, it also blocks cholinergic signaling through its actions on postsynaptic receptors.  We 
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expected that if a certain degree of ACh signaling were indeed necessary for SAT performance, 
the animals’ ability to discriminate between signal and nonsignal events would be impaired 
during drug perfusion.  Additionally, we confirmed that task-associated ACh-release relies on 
impulse-dependent neurotransmission by adding 1 µM of the voltage-gated sodium channel 
blocker tetrodotoxin (TTX) to the perfusion medium for a brief period during a single SAT 
dialysis session. 
In a second experiment, we taxed the mPFC cholinergic system pharmacologically by 
perfusing, via reverse dialysis, atropine, which evokes increased ACh release in rats (Moore, 
Stuckman, Sarter, & Bruno, 1995).  We expected that while WT mice would similarly show 
increased ACh release over the course of the drug, CHT +/- mice would be unable to sustain 
heightened levels of choline-uptake and ACh release due to an insufficient intracellular CHT 
reserve pool.  In addition, CHT +/- mice express fewer M2 autoreceptors in the cortex, 
suggesting that atropine may be less effective at inhibiting ACh negative feedback mechanisms 
(Bazalakova & Blakely, 2006).  Consistent with our hypothesis, we found that CHT +/- mice 
were unable to release elevated levels of ACh for as long a time period as WT mice. 
Together, the two experiments aimed to tax cholinergic signaling in order to elucidate 
differences in ACh release patterns between WT and CHT +/- mice.  Understanding such 
differences is a critical step in understanding the normal regulation of CHT trafficking and 
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capacity as well as the limitations and compensatory mechanisms associated with CHT 
hemizygosity. A major undertaking of this study was to perform microdialysis, which enables 
detection of ACh, on freely moving mice.  While microdialysis has been previously conducted 
on anesthetized mice, this is, to our knowledge, the first study to employ the method in awake 
and performing mice.  By overcoming the many challenges that arose due to the novelty of the 
procedure (see discussion), we were able to refine a technique that will benefit future studies of 
genetically modified mice. 
Method 
Subjects 
 WT and CHT +/- C57Bl/6J mice were bred at the University of Michigan.  Male and 
female mice weighing 20-25 g prior to the onset of training were housed individually in a 
humidity (45%) and temperature (23 qC) controlled environment.  Animals were kept on a 
12hrlight/dark cycle (lights on at 7:30 A.M.) and trained and tested during the light phase.  
Performing mice were gradually water deprived over a one-week period prior to the onset of 
training, with ad libitum access to food.  Animals received water as a reward during task 
performance and for 3 min following completion of the task.  On days not tested, animals 
received 10 min water.  A separate, nonperforming, group of mice was used in the second 
experiment, and provided with ad libitum access to food and water. 
ATTENTION AND ACETYLCHOLINE RELEASE IN CHT +/- MICE 
 
11
Behavioral Training Procedure 
 The training and testing took place in operant chambers (20 u 24 u 29.8 cm; width u 
length u height), situated inside sound-attenuated chambers.  Each operant chamber contained an 
intelligence panel equipped with two lights (2.8 W), two retractable nose-pokes, and a water 
dispenser (6 µL of 0.2% Saccharin in de-ionized water per delivery).  A house light (2.8 W) was 
located on the rear wall.   
 Mice were trained on a SAT modified from the version used with rats (McGaughly & 
Sarter, 1995).  Animals were initially shaped to reach the water dispenser using a modified fixed 
ratio-1 (FR-1) reward schedule.  After obtaining 100 water rewards for three days, animals 
began training on the SAT.  SAT training began with a series of levels in which animals learned 
to distinguish between signal (illumination of the central panel light) and non-signal (no 
illumination) events.  Importantly, the house light was kept off, making the signal more salient.  
On signal trials, a left nose-poke was termed at “hit,” while a right nose-poke was termed a 
“miss.”  On non-signal trials, a right nose-poke was termed a “correct rejection,” while a left 
nose-poke was termed a “false alarm.” Half of the animals were trained following the reverse 
rules.  Only hits and correct rejections were rewarded. An omission was recorded if the animal 
failed to nose-poke during the nose-poke extension following an event.  Signal and non-signal 
trials were presented in a pseudorandom order. 
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 In the first task level, a longer cue (5 sec) illuminated during signal trials. 1 sec after 
signal onset, both nose-pokes extended for 4 sec.  In non-signal trials, nose-pokes extended for 4 
sec.   Incorrect responses were followed with up to three correction trials, during which the 
previous trial was repeated.  If the animal failed to respond correctly to all three correction trials, 
a forced trial was initiated, during which only the nose-poke corresponding to the correct 
response extended.  After reaching criterion (at least three consecutive days of obtaining >60% 
hits and correct rejections) animals moved to the subsequent level, in which signal length and 
time delay before nose-poke extension were reduced (1 sec and 0.5 sec, respectively).  After 
reaching criterion (same as previous level), animals moved to next level, during which the length 
of the signal varied (either 500, 50, or 25 ms) throughout the session.  The session consisted of 
five, 8-min blocks, designed to ensure equal numbers of signal and non signal trials, as well as 
500, 50 or 25 ms signals. Trial type and signal duration were presented in a pseudorandom order, 
with approximately 160 trials per session and an inter-trial interval of 12 ± 3 sec.  Forced and 
correction trials were eliminated at this point.   
 After reaching criterion at this stage (three days of obtaining a SAT score >0.6, see below 
for an explanation of SAT score), animals moved to the final level of the SAT (the real sustained 
attention task per se) during which the house light was illuminated. After stable performance for 
at least three days (hits and correct rejections >0.60, omissions <0.20) some animals were 
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exposed to the distractor (house light flashes on/off at 0.5 Hz) during task blocks 2 and 3. 
Following a distraction session, animals were trained on the SAT for three days or until returning 
to criterion.  When performance on the SAT was stable at criterion, animals were surgically 
implanted with guide cannulas to allow for microdialysis.   
Surgical Method 
 Animals were placed in an anesthetic chamber and administered 2-3% isoflurane. Prior to 
operation, animals were injected with an antibiotic (Amoxicillin, 100 mg/kg) and atropine (0.05 
mg/kg) subcutaneously.  The animals’ heads were shaved with electric clippers and cleaned with 
ethanol and a topical antiseptic, and animals’ eyes were lubricated with opthalmic ointment. 
Throughout the surgery, body temperature was maintained using an isothermal heat pad.  
Animals were set in a stereotaxic instrument, and 1-3% isoflurane was administered 
continuously during the surgery via a face-mask.  A microdialysis guide cannula (CMA 7) was 
implanted into the mPFC of the right hemisphere according to the following coordinates, relative 
to Bregma: AP: +1.8 mm, ML: -0.4 mm, DV: -0.1 mm.  These coordinates placed the tip of the 
probe 2.1 mm beneath the dura surface.  The guide cannula was secured to the skull using 
stainless steel screws and dental cement.  To prevent clogging of the guide cannula, a stainless 
steel stylet was inserted until microdialysis sessions, at which point it was replaced by a 2 mm 
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probe (CMA 7MD).  Post-surgery, animals were returned to their cages and allowed to recover 
for at least 7 days before dialysis.   
Microdialysis Procedure 
 Up to four microdialysis sessions, separated by at least five days, were conducted on each 
animal while performing the SAT. After surgery animals resumed SAT training in modified 
operant chambers that contained a taller water delivery area and openings in the ceilings of the 
operant and sound attenuating chambers to accommodate the microdialysis tubing.  Furthermore, 
animals were tethered with polyethylene tubing to mimic dialysis conditions.  Microdialysis was 
conducted once SAT performance returned to stable performance on criterion.  On one animal, 
microdialysis was conducted during dSAT performance. 
 At the beginning of the test session, the stylet was removed and a probe was inserted 
through the guide cannula into the mPFC.  Mice were perfused at a rate of 2 µl/min with 
artificial cerebral spinal fluid (aCSF), pH 6.8 ± 0.1, containing the following (in mM): 126.5 
NaCl, 27.5 NaHCO3, 2.4 KCL, 0.5 Na2SO4, 0.5 KH2PO4, 1.2 CaCl2, 0.8 MgCl2, and 5.0 
dextrose.  After a 2 hr stabilization period, six 8-min baseline dialysates were collected and the 
last three used to calculate basal ACh release. The SAT then began, and five 8-min dialysates 
were collected after a 3:40 min wait period that accounted for the dead volume of the probe and 
outlet tubing.  Five 8-min collections were taken after completion of the task.   
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During one SAT session, TTX (1 µM) was dissolved in aCSF and perfused, via reverse 
dialysis, for the duration of the third and fourth blocks of the task.  The input line was switched 
to the drug-containing syringe prior to the third SAT block, with adequate time allotted for the 
dead-volume of the probe and tubing inlet, and switched back to the aCSF containing syringe 
prior to the fifth block.  In a different session, atropine (50 µM) was dissolved in aCSF and 
perfused, via reverse dialysis, during task (blocks t2-t5).  At the conclusion of the session, probes 
were removed and replaced with stylets, and animals returned to their cages. 
 In the second experiment, to test differences in ACh release in response to atropine, 
microdialysis was conducted on a group of nonperforming animals (WT: n = 4, CHT: n = 2).  
The basic dialysis procedure was the same as that described above, with the following 
modifications.  Dialysis took place in the animals’ home cage, and acclimation to testing 
conditions required staying in the testing room, tethered for 4 hr each on five separate days.  
During the test session, a 2 hr stabilization period was allowed after probe insertion before six 8-
min baseline dialysates were collected.  The microdialysis tubing was then switched to a second 
syringe containing 50 µM atropine dissolved in aCSF.  Collections resumed after a 6-min wait-
period to allow for the dead-volume of the probe and inlet and outlet tubing. Four 8-min 
collections were taken as the drug was perfused.  The perfusion medium was then switched back 
to aCSF, and 5 post-drug collections were taken after the dead-volume wait-period.   
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Determination of ACh Concentrations 
 Dialysate samples were kept at -80 ºC until analyzed with high-performance liquid 
chromatography (HPLC) with electrochemical detection. 
Histological Verification of Probe and Cannula Placements 
 Animals were perfused within one week after the last microdialysis session.  The brains 
were preserved in formalin overnight and then transferred to a 30% sucrose phosphate buffer 
solution.  Sections (35 µm) near the probe and cannula sites were mounted on glass slides, Nissl-
stained, and examined to confirm the cannula and probe placements. 
Behavioral measures 
 Hits, misses, correct rejections, false alarms, and omissions were recorded for each SAT 
session. Performance was assessed according to the SAT score, defined as (h-f)/[2(h + f) – (h + 
f)2], where h is the relative number of hits and f is the relative number of false alarms.  Scores 
range from +1.0 to –1.0, with +1.0 indicating all responses were hits and correct rejections, –1.0 
indicating all responses were misses and false alarms, and 0 representing chance performance 
(the animal is unable to discriminate between signal and nonsignal events).  SAT scores were 
calculated separately for each signal duration (SAT500,50,25), the average of which was taken as 
the SAT score.  Measures of performance were calculated separately for each of the five, 8-min 
task blocks. 
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Statistical Analyses 
 Performance data analyses.  Complete sets of SAT performance data were available 
from five WT and six CHT +/- mice. Upon reaching criterion on the SAT, data from three 
consecutive days of stable performance was analyzed to establish baseline performance. Mixed 
analysis of variance (ANOVA) was used to determine the effects of sex (male vs. female), 
genotype (WT vs. CHT +/-), task block (t1–t5) and signal duration (500, 50, or 25 ms) on 
performance.  
 ACh release.  In each dialysis session, the last three baseline collections were averaged 
to calculate basal ACh release.  Task and drug-associated release values were expressed as a 
percent change from baseline.  Basal release was constant across dialysis sessions and also 
comparable between performing and nonperforming mice.  Therefore, all sessions were 
collapsed to determine the average basal release for WT and CHT +/- mice.  Performance-
associated ACh release was evaluated using a paired t-test comparing basal release to release 
over the task blocks.  Interactions between genotype and perfusion of atropine were assessed 
using a genotype u drug mixed ANOVA with drug as a repeated measure.  Post hoc analyses are 
described further with the results.     
 General statistical methods.  In cases in which the sphericity assumption was not met, 
Huyhn-Feldt-corrected F values are given; degrees of freedom were not adjusted. 
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Results 
Measures of performance 
There was no difference in SAT score between male and female mice, as demonstrated 
by a lack of effect of sex on SAT score in a block (5) u duration (3) u sex (2) mixed ANOVA, 
F(1,9) = 0.07, p = 0.795.  Thus, data from male and female mice were collapsed for further 
comparisons.  WT and CHT +/- mice scored comparably on all measures of task performance, as 
illustrated in Figure 1.  There was no difference in overall performance (SAT score ± SEM: WT: 
0.30 ± 0.03, CHT +/-: 0.27 + 0.02), as indicated by a lack of effect of genotype on SAT score 
(main effect of genotype: F(1,9) = 0.19, p = 0.674).  There was no main effect of genotype on 
hits [F(1,9) =  0.09; p = 0.784], correct rejections [F(1,9) = 0.00; p = 0.980], or omissions [F(1,9) 
= 0.19, p = 0.677].  As expected, there was a significant effect of signal duration on signal trial 
responses (main effect of duration, F(2,18) = 91.68, p = 0.000).  In a dialysis session conducted 
on a CHT +/- mouse performing the dSAT, we observed only a marginal impairment in 
performance.  The dSAT score was 0.11 bellow the average SAT score of the previous three 
days.  Compared to the first block, hits were 7% lower in the distractor blocks and 7% higher in 
the block following distractor.  
Basal ACh release 
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Basal release did not vary between nonperforming and performing animals (WT: t(3) = 
0.35, p = 0.748, CHT +/-: t(6) = 1.60, p = 0.161).  There was also no difference in basal release 
between WT and CHT +/- mice (basal release ± SEM: WT: 6.34 ± 0.34 pmol/15 µL; CHT: 6.56 
± 0.52 pmol/15 µL; t(11) = 0.82, p = 0.430).  Repeated measures ANOVA revealed that basal 
release remained steady across four dialysis sessions, F(3,12) = 2.47, p =0.112. 
SAT/dSAT performance-associated ACh release 
 SAT performance-associated increase in ACh release, measured in the mPFC is 
illustrated in Figure 2. Due to the small WT subject pool (n = 1), statistical comparisons between 
groups were not conducted.  Among CHT +/- subjects, ACh release over the task blocks (t1-t5) 
was averaged and compared to average baseline release, revealing a trend towards SAT-
associated ACh release, t(3) =  2.55, p = 0.084.   Repeated measures ANOVA comparing the 
task blocks showed that release remained steady across the task (main effect of task block: 
F(4,12) = 1.42, p = 0.297).  ACh release during the task blocks was higher in WT than CHT +/- 
mice [WT (n = 1): 107.46%; CHT (n = 4): 36.93 ± 6%].  A preliminary dialysis session was 
conducted on a CHT +/- mouse performing the dSAT (see Figure 3).  ACh release was greatest 
in the block immediately following the distractor (49.4%). 
SAT with perfusion of atropine 
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 To determine the effect of ACh signaling blockade on task performance in CHT +/- mice, 
the muscarinic ACh receptor antagonist atropine was perfused during blocks t2-t5 of one SAT 
session.  ACh levels increased 111% above baseline during reverse dialysis of atropine and 
remained elevated after the task/drug period (see Figure 4).  During drug perfusion, omissions 
increased by 162.8%, hits increased by 21.9% and correct rejections decreased by 5.9%. 
Impaired ACh release with TTX 
 To demonstrate that task-associated ACh increases were dependent on local 
depolarization of axons, we administered 1 µM of the voltage-gated Na+ channel blocker TTX 
through blocks 3 and 4 during one SAT session (see Figure 5).  By the second collection 
following drug administration, TTX completely abolished the task-associated ACh increase 
observed during blocks one and two, with ACh levels falling on average 43% below baseline 
over four collection periods.  Performance during blocks 4 and 5 was also affected, with the SAT 
score dropping by 0.38 points, and hits dropping by 43%.   
Atropine-induced ACh release in nonperforming mice 
Atropine (50 µM) was perfused in nonperforming WT and CHT +/- mice to investigate 
differences in the ability to sustain elevated ACh release (see Figure 6).  To analyze for possible 
effects of atropine as a function of group, the mean of the 4 atropine collections was calculated, 
and this value and the average baseline release were subjected to a genotype (2) u drug (2) mixed 
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ANOVA.  Reverse dialysis of atropine was associated with increases in cortical ACh release, as 
indicated by a main effect of drug, F(1,4) = 54.24, p = 0.002.  Post hoc analysis confirmed a 
significant difference between the average baseline collections and the first drug collection, t(5) 
= 3.05, p = 0.028.  A main effect of genotype did not reach statistical significance, and ACh 
increases during the first collection were comparable (WT: 88.49 ± 28%; CHT: 117.96 ± 57%). 
However, while WT release levels remained elevated over the drug period, CHT +/- release 
levels showed a tendency to drop back to baseline after the first drug collection period.    
Discussion 
 The present study is the first to conduct microdialysis in the mPFC in freely moving and 
performing mice and establishes a research method that will benefit future studies.  The ability to 
associate ACh release levels with behaviors in mice genetically modified to model diseases will 
add to our understanding of normal functioning and disease processes.  The procedure described 
above was refined as complications arose over the course of the study. For example, several pilot 
studies were required to adjust the coordinates, relative to bregma, for guide cannula placement.  
Following surgery, we had to determine if mice could break the photo-beams of the nose-pokes, 
and then modify the water-delivery ports to allow access to water.   
 We discovered that compared to rats, mice require a longer recovery period between 
consecutive dialysis sessions.  This was especially true amongst CHT +/- mice, possibly because 
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of vulnerability to cardiovascular complications due to impaired CHT capacity in the autonomic 
nervous system (English et al., 2010).  To help speed recovery, we provided CHT +/- mice with 
a heating pad and ad libitum access to water for two days following each dialysis session.  Mice 
also required more time (approximately two weeks) to return to criterion performance levels on 
the SAT following surgery.  A number of mice had to be excluded from our microdialysis data 
because their performance on the SAT never returned to criterion following surgery.  The 
atropine study also required extensive piloting, as three doses (5 µM, 50 µM, and 100 µM) of 
drug were tested before determining which to use in our study.  We selected the intermediate 
dose, at which results were most consistent and drug-related ACh release increases were 
observed for both WT and CHT +/- mice.   
 Another accomplishment of this study was obtaining detectable levels of ACh release 
without the addition of an acetylcholinesterase inhibitor.  Most dialysis studies of mice have 
relied on the local perfusion of neostigmine to facilitate the detection of low levels of ACh.  
However, because acetylcholinesterase inhibitors cause ACh levels to remain elevated by 
reversibly inhibiting ACh breakdown in the synapse, the use of such drugs is not ideal in studies 
that aim to distinguish potentially important patterns of ACh release across time. 
 We found that basal ACh release was comparable between WT and CHT +/- mice, 
consistent with the current understanding that CHT +/- mice have equivalent basal levels of CHT 
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localized at the synaptosomal membrane (Sarter & Parikh, 2005).  In nonperforming mice, we 
observed that CHT +/- mice released ACh levels equal to WT during the first 8-min block of 
drug perfusion, but were unable to sustain this elevated release for the remainder of the drug 
period.  This release pattern is congruent with the prevailing model of the CHT +/- deficiency, in 
which sustained, heightened ACh synthesis and release are limited by a reduced intracellular 
CHT reserve pool.  In both WT and CHT +/- mice, atropine may initially induce trafficking of 
CHT from intracellular stores to the membrane to enable elevated ACh synthesis and release.  
However, as these intracellular stores are depleted, CHT hemizygotes are unable sustain 
heightened ACh turnover. 
 The release pattern observed during CHT +/- task performance looked quite different 
from that observed in nonperforming animals.  During the task blocks we observed a |30% 
increase in ACh release, substantially lower than the |100% increase seen in the WT.  
Intriguingly, despite lower levels of performance-associated ACh release, CHT +/- mice 
performed equally well to WT on all measures of the SAT.  While an interpretation of these 
surprising results will follow, a clear limitation of this study was the restricted number of WT 
microdialysis data available for analysis.  Further experiments will include a larger sample size 
to confirm the findings here.  Encouragingly, the ACh release pattern exhibited by the WT task-
performing mouse in this study was congruent with previous findings in rats.  For example the 
ATTENTION AND ACETYLCHOLINE RELEASE IN CHT +/- MICE 
 
24
|100% increased release observed during the first task block was comparable to the 138.2 ± 
14.24% reported in SAT-performing rats (Kozak, Bruno, & Sarter, 2006).  Likewise, we found 
an average task-associated increase of 107.46%, consistent with the 88.70 ± 19.28% increase 
reported in rats (St. Peters et al., 2011). The finding that CHT +/- mice performed equally well 
despite lower levels of ACh release demonstrates an impressive ability of CHT +/- mice to 
compensate for reduced CHT capacity and provokes many questions.   
 First, it appears that the SAT alone does not sufficiently tax the cholinergic system to 
reveal differences in attentional performance that may be inherent of CHT hemizygosity. To 
investigate this possibility, we began training mice on the dSAT and conducted a preliminary 
dialysis session on a CHT +/- mouse.  We observed the greatest ACh release not during the 
distractor blocks, as we had originally predicted, but in the block immediately following. This 
finding was especially intriguing in light of recent findings that suggest CHT +/- are more 
impaired than WT on signal trials in the block following the distractor (unpublished findings, 
Sarter, 2009). As increased cholinergic neurotransmission has been linked to attentional effort, 
the increased ACh release observed after the distractor may reflect the animal’s attempt to 
recover performance.  Further dialysis sessions during dSAT performance are needed to explore 
differences in ACh release patterns between WT and CHT +/- mice.  If performance on the 
dSAT turns out to be equivalent in future studies, we expect to find that fluctuations in ACh 
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release during dSAT are mirrored in WT and CHT +/- animals, but on different scales.  
However, if CHT +/- mice continue to show an impaired ability to recover from the distractor, 
we predict that CHT +/- mice will not be able to reach proportionally high post-distractor release 
levels.   
 After finding that CHT +/- mice perform the SAT and dSAT with only a small amount of 
ACh release, we were interested to determine if the small increase in cholinergic signaling is in 
fact required for attentional performance.  In an initial attempt to address this question, we 
blocked local ACh signaling by perfusing the muscarnic ACh receptor antagonist atropine during 
task.  Beginning in the second block after drug onset, we observed a robust increase in 
omissions.  While this may be an initial indication that ACh is required for attentional 
performance, the fact that signal and nonsignal responses were unimpaired makes it difficult to 
interpret the specific effects of the drug.  Likely the animal’s behavior was altered as it became 
aware of its “drug-state.”  Subsequent experiments will include a lower dose of atropine, which 
will hopefully allow for determination of the specific effects of ACh signaling blockade.   
 More illuminating will be lesions of the basal forebrain cholinergic neurons, effectively 
blocking cholinergic transmission to the mPFC.  Similar lesions, conducted in rats after reaching 
criterion on the SAT, showed cholinergic inputs to the mPFC to be critical for performance 
(Martinez, & Sarter, 2004).  If CHT +/- mice are able to recover performance after these lesions, 
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we must investigate the alternative strategies and signaling pathways employed by hemizygotes 
to accomplish the SAT.  We can at this point only speculate as to the compensatory mechanisms 
CHT +/- animals develop throughout life (for example, down regulation of postsynaptic 
receptors, re-regulation of autoreceptors, or recruitment of different neurotransmitter systems to 
perform attention tasks).  
 Our data support the model that CHT +/- mice are unable to sustain elevated levels of 
ACh release, further validating the use of these mice to model diseases associated with impaired 
CHT capacity.  The fact that we were unable to detect phenotype differences suggests that these 
animals are able to impressively compensate for their reduced CHT capacity to maintain 
sustained attention.  These findings, as well as future research regarding the limitations of the 
CHT +/- genotype and the compensatory mechanisms enabling sustained attentional performance 
will help in understanding diseases associated with altered CHT functioning. 
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Figure 1. Sustained Attention Task performance of WT (n = 5) and CHT +/- (n = 6) mice.  
Measures of performance were averaged over three consecutive days at criterion.  Hits, correct 
rejections, and omissions were comparable between WT and CHT +/- groups. 
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Figure 2.  Acetylcholine (ACh) release in the medial prefrontal cortex of CHT +/- (n = 4) and 
WT (n = 1) mice performing the Sustained Attention Task (SAT).  Vertical lines indicate the task 
period.  Among CHT +/- animals, ACh release during SAT performance was not significantly 
different from baseline release.   
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Figure 3.  ACh release during performance on the dSAT. The visual distractor was presented 
during task blocks 2 and 3, as indicated by the shaded box.  This graph depicts the performance-
associated ACh release of a CHT +/- mouse (n = 1).   
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Figure 4. Effects of atropine on mPFC ACh release in a SAT-performing CHT +/- mouse.  The 
shaded box indicates the time during which atropine (50 PM, n = 1) was perfused via reverse 
dialysis.  This manipulation was designed primarily to block cholinergic signaling in the mPFC.  
The increases in ACh release observed are due to the drug’s inhibitory effect on presynaptic 
autoreceptors.  Note that the AT1 and AT2 values (indicated by asterisks) are misrepresented on 
the graph in order to allow better visualization of the task-associated release.   
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Figure 5.  Effects of reverse dialysis of tetrodotoxin (TTX) on performance-associated ACh 
release in the mPFC.  This graph depicts two different dialysis sessions performed on the same, 
CHT +/- mouse (n = 1).  In one session TTX (1 PM) was perfused via reverse dialysis through 
blocks t3 and t4; in a control session, aCSF alone was perfused. This manipulation was designed 
to show that task-associated increases in ACh release are dependent on impulse-dependent 
transmission within the mPFC.   
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Figure 6.  Temporal pattern of ACh in the mPFC following reverse dialysis of atropine (50 PM) 
in nonperforming CHT +/- (n = 2) and WT (n = 4) mice.  ACh release during the first drug 
collection (D1) was significantly higher than average baseline release (p<0.05).  An effect of 
genotype did not reach statistical significance, likely due to a lack of statistical power. CHT +/- 
mice released levels of ACh comparable to WT during the first drug collection period, but 
appeared unable to sustain this elevated release over the remaining collections. 
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